Recently, substantial evidence has accumulated for the existence of a second lissencephaly gene on the X Summary chromosome. Linkage analysis from two studies (des Portes et al., 1997; Ross et al., 1997) provides strong X-linked lissencephaly and "double cortex" are allelic evidence that a single gene maps to Xq21-24, with a human disorders mapping to Xq22.3-Xq23 associated pooled multipoint LOD score of approximately 4.2 and with arrest of migrating cerebral cortical neurons. We informative recombination events that place the gene identified a novel 10 kb brain-specific cDNA interin an approximately 12 cM interval between markers rupted by a balanced translocation in an XLIS patient DXS8020 and DXS1072. In affected pedigrees, males that encodes a novel 40 kDa predicted protein named with X-linked lissencephaly (XLIS) display a phenotype Doublecortin. Four double cortex/X-linked lissencephessentially indistinguishable from lissencephaly caused aly families and three sporadic double cortex patients by chromosome 17 mutations (Dobyns et al., 1996 ; Berg show independent doublecortin mutations, at least et al., 1997). Affected females heterozygous for the one of them a de novo mutation. Doublecortin contains X-linked mutation show a milder phenotype, presumably a consensus Abl phosphorylation site and other sites representing a mosaic state caused by random inactivaof potential phosphorylation. Although Doublecortin tion of either the mutant or normal X chromosome. The does not contain a kinase domain, it is homologous brains of affected females ( Figure 1 ) show a population to the amino terminus of a predicted kinase protein, of neurons that behaves normally and a population that indicating a likely role in signal transduction. Doumigrates approximately halfway to the cortex and then blecortin, along with the newly characterized mDab1, arrests in the subcortical white matter, producing a band may define an Abl-dependent pathway regulating neuof neurons called subcortical band heterotopia or "douronal migration.
ble cortex" (DC) (Raymond et al., 1995; Harding, 1996) . The majority of patients with DC are female, presumably representing mutations in the X-linked locus.
Introduction
The mapping of double cortex/X-linked lissencephaly (DC/XLIS) to Xq21-q24 is intriguing because of a preThe cerebral cortex shows a precise layering of multiple viously described female patient with lissencephaly neuronal types with distinct form and function, and this associated with a de novo, apparently balanced X;2 (q22;p21) translocation within the candidate region (Dobyns et al., 1992) . Such X;autosome translocations often 9 To whom correspondence should be addressed. 10 These authors contributed equally to this work.
result in females that exhibit the male phenotype, as the MRI from a female patient with double cortex syndrome is shown in (A). The image is taken in a coronal plane and shows the cortex and cerebellum. A postmortem specimen of a double cortex brain, in the same plane as the MRI in (A), is shown in (B). The outer cortex (star) is normal but with a band of gray matter (arrow) embedded within the white matter beneath the cortex, representing the "double" cortex (also referred to as band heterotopia, or subcortical laminar heterotopia).
normal X chromosome is preferentially inactivated to #GM11172) derived from a different X;2 translocation containing X chromosomal DNA only distal to Xq21.3 retain autosomal euploidy. Hence, the mapping data suggests that the translocation disrupts the function of (in order to verify that the STS maps to the telomeric q arm of the X chromosome); and (4) a further YAC library the DC/XLIS gene. Here we report the positional cloning of a large brain-specific cDNA spanning this X;2 transloscreen. YAC-end STSs, which mapped back to the X chromosome but were absent from JFA6, were interprecation breakpoint, which encodes a novel 40 kDa predicted protein called Doublecortin. Independent mutated as centromeric to the translocation breakpoint, and YAC ends present in JFA6 were interpreted as telomeric tions in the doublecortin gene were identified in four pedigrees with DC/XLIS as well as in additional sporadic to the breakpoint. Serial rounds of YAC identification and YAC-end isolafemales with DC. Doublecortin contains a predicted Abl phosphorylation site and several other potential sites tion identified several YACs that showed one end present and one end absent in JFA6, indicating that these for phosphorylation by other kinase proteins, suggesting a tyrosine kinase signal transduction pathway may conYACs spanned the translocation breakpoint. One such YAC (4X148D1), obtained from the ICRF library control neuronal migration.
taining small average insert size, was subcloned to make a cosmid library. Cosmids were arrayed into a contig Mapping of the X;2 (q22;p21) Breakpoint by restriction mapping, by PCR with previously identified Previous work (Ross et al., 1997) had identified marker YAC-end STSs, and by using new STSs corresponding DXS1105 as the closest published proximal (centroto the end sequence of individual cosmids (Figure 2 ). In meric) marker and DXS1072 as the closest published addition, two human BAC libraries were screened with distal (telomeric) marker to the translocation breakpoint.
AFM340za9, which identified two BACs. Further mapping of the breakpoint by PCR narrowed Sequence of BAC and cosmid ends were obtained the candidate region to between DXS287 and DXS1072 either by using linker-mediated PCR as for YACs, by based on the current X-chromosome physical map (Sricreating internal deletions of the clone, or by sequencing vastava et al., 1995) . In order to generate a physical map the clone directly. STSs corresponding to cosmid and in the region of the translocation breakpoint, two YAC BAC ends were tested in JFA6 in order to identify cos-(yeast artificial chromosome) walks were initiated from mids (A10, C3, C12, D11) that contained one end present DXS287 and AFM340za9 proximally, and from DXS1072 and one end absent in JFA6, suggesting that these distally, with each YAC walk progressing centrally to smaller clones spanned the translocation breakpoint. attempt to fill the "hole" in between (K. M. A., J. G. G., Data for cosmid A10 is shown in Figure 3A . BACs and and C. A. W., unpublished data). For each YAC isolated, cosmids were organized into a single contig that crossed the DNA at the termini of the YAC was amplified using the breakpoint of the Xq22 translocation with greater linker-mediated PCR and sequenced. For each YAC end than 3-fold coverage. Selected clones are depicted in successfully sequenced, a new pair of primers was de- Figure 2 . signed in order to amplify a sequence-tagged site (STS)
The PCR results using STSs designed to the ends of within that YAC end. Each new STS was then used as the cosmids suggested that several cosmids spanned a PCR reaction in (1) normal genomic DNA; (2) genomic the translocation but did not exclude the existence of DNA isolated from the somatic cell hybrid line JFA6 a rearrangement or deletion at the site of the transloca-(Coriell Cell Repository #GM12515) derived from the X;2 tion in JFA6. Therefore, cosmid A10 was used as a probe (q22;p21) translocation patient and thus containing X for FISH in the parental X;2 translocation cell line conchromosomal DNA only distal to the Xq22 translocation taining the full complement of human chromosomes breakpoint (the derivative chromosome 2) (Ross et al.,
( Figure 3B ). Hybridization signal from cosmid A10 was 1997); (3) genomic DNA isolated from a similarly prepared somatic cell hybrid BEN3B (Coriell Cell Repository seen on the normal X chromosome and on the derivative X chromosome centromeric to the translocation breaksingle 1814 bp human fetal brain EST called HFBCY45, suggesting that these three areas of homology reprepoint (it is not surprising that cosmid A10 did not show detectable hybridization signal distal to the translocasented putative exons of the HFBCY45 cDNA. Surprisingly, STSs designed to the three exons showed that tion as sequencing data revealed that the majority of cosmid A10 lies proximal to the translocation breaktwo were present and one was absent from JFA6 ( Figure  3C ), suggesting that the HFBCY45 transcript spanned point). PCR results demonstrating that part of cosmid A10 was present telomeric to the breakpoint and FISH the translocation. Southern analysis with HFBCY45 in the parent cell line carrying the X;2 translocation showed results demonstrating that part of cosmid A10 was present centromeric to the breakpoint confirm that the transtwo novel restriction bands with multiple restriction enzymes ( Figure 3D ), confirming that HFBCY45 indeed location is not associated with a gross rearrangement or deletion and that cosmid A10 spans the translocation spanned the translocation breakpoint. Northern analysis showed HFBCY45 hybridizing to a single 10 kb message breakpoint in the X;2 lissencephaly patient.
expressed exclusively in developing brain ( Figure 4A ). Identification of a cDNA Interrupted by the X;2 Translocation Elimination of a PAK Gene As a Candidate for DC/XLIS Cosmid A10 was subcloned into Bluescript and sequenced, forming a single DNA sequence contig Ͼ35 DNA sequence analysis of two short stretches (≈90 bp) from the end of another YAC 4X148D1-derived cosmid kbp. BLAST analysis of this sequence did not detect significant homology throughout any of its sequence to (H1) located approximately 160 kbp from the translocation breakpoint ( Figure 2 ) showed a 92% match to the the coding region of known genes. Analysis of A10 with restriction enzymes that recognize CpG islands (AscI, recently cloned rat ␤-PAK (Manser et al., 1995) and mouse mPAK-3 genes (Bagrodia et al., 1995) , sugMluI, NotI, NarI, SmaI) showed no more than one recognition sequence for each of these enzymes, suggesting gesting that these two short stretches represented two exons of the human homolog of these rodent genes. that A10 contained very few genes. One fragment of DNA sequence from A10 was 98% identical to the full We refer to the human homolog of these rodent genes as hPAK3/␤PAK. The PAKs (p21-activated kinases) are 436 bp of an EST (GenBank clone ID 417033) from the Soares human fetal liver spleen library. However, Northa well-characterized family of signal transduction molecules that are involved in changes in cell morphology ern analysis of this clone did not detect any transcript in fetal brain (data not shown) and this sequence was and actin organization (Sells et al., 1997) , making hPAK3/ ␤PAK an attractive candidate gene for a disease in which not analyzed further.
BLAST analysis of a second sequence from A10 demigration of neurons is defective. The full coding region for hPAK3/␤PAK was identified within a 2.5 kbp cDNA tected Ͼ97% identity of three regions of sequence to a contig using a combination of rapid amplification of probes recognize transcripts of distinct size and temporal expression pattern in mouse. The HFBCY45 trancDNA ends (RACE) and cDNA library screening. Northern analysis of hPAK3/␤PAK identified a 10 kb message script is 9.5 kb and maximally expressed at E11, while the mPAK-3 message is 9 kb and expressed equivalently present exclusively in the developing brain similar in size and expression to the band that hybridized to HFBCY45 at E11, E15, and E17 ( Figure 4B ). These data strongly suggested that the two human cDNAs are encoded on (data not shown), suggesting initially that HFBCY45 might be part of the hPAK3/␤PAK mRNA. distinct messages, implying that the hPAK3/␤PAK mRNA is not interrupted by the X;2 translocation. In order to evaluate hPAK3/␤PAK as a candidate gene for DC/XLIS, we identified 13 of 14 exons from genomic DNA covering 95% (1564 of 1653 bp) of the ORF (open reading frame) (J. G. G., K. M. A., and C. A. W., unpubIdentification of a Novel Gene, doublecortin, Interrupted by the X;2 Translocation lished data) and evaluated these 13 exons for mutations in 56 unrelated DC patients using single-stranded conIn order to further characterize the transcript interrupted by the X;2 translocation, HFBCY45 was used as an initial formational polymorphism analysis (SSCP). No polymorphisms were found in any patients. Furthermore, Southprobe to screen a lambda fetal brain cDNA library with positive clones organized into a contig based upon their ern blot analysis of 23 unrelated DC patients probed with 500 bp of hPAK3/␤PAK 5Ј ORF did not reveal any sequence. Sequences from the distal ends of the largest clones were used to generate probes for subsequent polymorphisms, implying that hPAK3/␤PAK is not causally related to DC/XLIS. rounds of screening; each new probe was confirmed to be part of the HFBCY45 transcript by Northern analysis. With the exclusion of hPAK3/␤PAK as causative for DC/XLIS, we suspected that HFBCY45 and hPAK3/ After four rounds of screening and a single 3Ј RACE reaction, a 9 kbp contig including a poly A tail was ␤PAK were, in fact, not part of a common mRNA. Initially, lambda screening, Northern analysis, and RT-PCR suggenerated from over 350 positive clones, the entirety of which represents unique sequence. Subsequent gested that HFBCY45 and hPAK3/␤PAK messages differ approximately 10-fold in abundance. Subsequent BLAST search analysis identified several GenBank ESTs, including accession numbers AA129192, AA081738, Northern analysis showed that HFBCY45 and mPAK-3 T07153, and T31616, which share greater than 99% seprepared from patients with DC/XLIS. Because of our concern about locus heterogeneity in lissencephaly and quence identity to the 3Ј end of the HFBCY45 contig.
Analysis of the new 9 kbp contig placed HFBCY45 DC, we concentrated initially on families with a clear X-linked pattern of inheritance. Nine pedigrees were annear the 5Ј end of the message and revealed that HFBCY45 partially defined a 1080 bp ORF, broken by alyzed for mutations in doublecortin by SSCP; all six coding exons were analyzed in two pedigrees, while only the X;2 translocation ( Figure 5A ). This ORF encodes a novel 360 amino acid, 40 kDa predicted protein that we the first two exons have been analyzed in the remaining seven pedigrees. Clear band shifts were identified in named Doublecortin.
The doublecortin transcript shows several interesting four pedigrees, three of which are presented ( Figure 6 ). In each pedigree analyzed, the novel SSCP conformer features. First, there are multiple alternative transcripts. Nearly half of the cDNA clones contained an additional cosegregated with the disease; males with lissencephaly displayed only the disease allele, while females with 18 bases within the ORF, introducing 6 additional amino acids that do not alter the reading frame (displayed in DC displayed both a normal and a disease allele, consistent with an X-linked dominant pattern of inheritance. Figure 5C ). Also, there is alternative splicing at the exon 8/9 junction, with an additional single amino acid (valine) Subsequent sequence analysis of the aberrant bands identified point mutations in all four pedigrees, each following amino acid K342 in half of the cDNA clones. In addition, three alternative splice forms of the 5Ј UTR leading to a nonconservative amino acid substitution (Table 1) . A limited screen for mutations in the first two of doublecortin were identified and extensively characterized, none of which are likely to extend the ORF furexons of the doublecortin ORF in sporadic female DC patients identified band shifts in several additional pather (data not shown). The significance of these alternative splice forms is not known. Second, doublecortin is tients. Subsequent sequence analysis from three patients identified frame shift mutations in each: a 2 bp characterized by a short 5Ј UTR (Ͻ500 bp), which we confirmed by RNAse H analysis (data not shown). douinsertion at position 36 from the ATG in patient 1, a 2 bp deletion at position 684-685 from the ATG in patient blecortin also has an unusually long 3Ј UTR (Ͼ7000 bp) that shows no BLAST homology and contains repetitive 2, and a 2 bp deletion at position 691-692 from the ATG in patient 3, each leading to premature protein sequences such as Alu elements and CA repeats. Finally, doublecortin is encoded over a large genomic termination. SSCP and sequence analysis from the unaffected parents of patient 3 demonstrated that this delesegment. Mapping the doublecortin ORF back to genomic DNA showed that the first 1122 bp of message tion represents a de novo mutation as neither parent harbors the mutant allele. Finally, a comprehensive mapped to cosmid A10, while the remaining sequence mapped to cosmid E4, approximately 100 kbp away.
SSCP screen of each of the six coding exons of doublecortin in 30 unaffected individuals yielded no polyTherefore, the doublecortin gene is a 1080 bp ORF encoded on a brain-specific, 10 kb message with six codmorphisms. the ORF of KIAA0369 extends an additional 1104 bp in predicted to be within the top 1% of Ͼ100,000 peptides tested. It is therefore likely that Doublecortin functions the 3Ј direction ( Figure 5C ). The carboxyl terminus of KIAA0369, not present in Doublecortin, is strikingly simias an intracellular signaling molecule, possibly as part of an Abl-dependent signal transduction pathway. lar at the amino acid level to the family of calcium calmodulin dependent kinases (CAM kinases) in the protein kinase ATP-binding domain and the serine-threonine Discussion kinase domain. The carboxyl terminus of KIAA0369 is 99% identical with CAM kinase CPG16 from rat (GenIn this report, we describe the characterization of a de novo balanced translocation in a patient with XLIS, the Bank U78857). However, Doublecortin does not share homology with the CAM kinase family over a significant construction of YAC and cosmid contigs in the region of the translocation, the identification of a single EST distance and does not encode a predicted kinase domain. Thus Doublecortin and KIAA0369 share substanthat spans the translocation breakpoint, and the construction of a 9 kbp cDNA contig based upon this EST. tial homology in their amino termini, but KIAA0369 likely functions as a kinase, possibly a CAM kinase.
Characterization of this message shows that it encodes a novel predicted protein named Doublecortin. douDoublecortin has no apparent consensus signal peptide or transmembrane sequences, and a protein blecortin is transcribed on a 10 kb brain-specific message which is alternatively spliced. Mutational analysis BLOCKS search revealed no conclusive matches. Doublecortin was also used to search the in both DC/XLIS pedigrees and sporadic patients with DC has identified numerous deleterious mutations in Web site CANSEARCH 1.0, which tests putative proteins against the results of a combinatorial peptide library doublecortin including nonconservative amino acid substitutions and frame shifts. No polymorphisms were deanalysis for selectivity of phosphorylation by signal transduction kinases (Songyang et al., 1995; Nishikawa tected in unaffected individuals. These data strongly suggest that doublecortin is the responsible gene for et al., 1997). Sequence analysis of Doublecortin revealed potential MAP kinase family phosphorylation sites at both DC and XLIS. Doublecortin is very similar to the putative brain protein KIAA0369 over nearly its entire amino acids T321, S327, T331, and S334. Doublecortin also showed a high likelihood of being phosphorylated sequence, although the carboxyl terminus of KIAA0369 extends further and appears to encode a potential CAM by Abl at tyrosine residue 70 ( Figure 5C ) with a specificity observations. First, it appears that the severity of the DC phenotype can be roughly correlated with the severity of the doublecortin mutation identified. The three sporadic patients who show frame shift mutations display very severe mental retardation, while the familial DC patients with single amino acid substitutions display mild or no mental retardation (J. G. G. and C. A. W., unpublished data).
It is also interesting to note that pedigree 2 appears to present a male lethal phenotype. This X-linked dominant pattern of inheritance with hemizygous male lethality has been observed in other human diseases including the neuronal migration disorder periventricular nodular heterotopia (PNH) (Eksioglu et al., 1996) . The mutation associated with the phenotypic severity seen in pedigree 2 may define a more critical region of Doublecortin or may suggest that a significant contribution to the DC/ XLIS phenotype is determined by the genetic background of the affected individual. This latter theory is supported by the observation that the X;2 translocation patient likely displays a full null allele yet has survived into early childhood.
Finally, a previous study (des Portes et al., 1997) suggested that DC/XLIS may show anticipation, with worsening phenotypes among females in subsequent generations. Mutational analysis in these families, however, does not support this claim. Anticipation is often seen in neurological diseases due to expanding trinucleotide repeats, but observations of anticipation are problematic in small pedigrees because of ascertainment and reproductive bias, since more severely affected individ- Given the striking similarity of Doublecortin to the amino change at amino acid 192, (E) a G-to-T mutation (C-to-A) results in an R-to-L change at amino acid 59, (F) a G-to-C mutation (C-to-G) terminus of a kinase protein (KIAA0369), and given that results in a T-to-R change at amino acid 203.
both proteins are expressed in the developing nervous system, Doublecortin may regulate the activity of kinases such as KIAA0369 by competing with these kinases in kinase. Doublecortin represents a likely substrate for binding to a regulatory protein. LIS1 is a candidate for Abl and a possible substrate for members of the MAPK this regulatory protein, since it is known to bind to the family and may therefore serve to transduce signals activated form of a different kinase, Syk, in the spleen critical for the migration of developing neurons. (Brunati et al., 1996) .
doublecortin Mutations in DC/XLIS Tyrosine Kinase Signaling and Neuronal Migration Analysis of the DC/XLIS pedigrees and doublecortin
Recent data have strongly implicated signaling processes through nonreceptor tyrosine kinases as critical mutations identified to date allows several interesting Mutations were identified in four pedigrees, and each represents a single amino acid substitution that alters charge. In each pedigree, affected males are hemizygous for mutations, while affected females are heterozygous. Mutations are also listed for three sporadic female patients with double cortex syndrome. Each of these represents an insertion or deletion of 2 bp that alters the translational reading frame, resulting in premature protein termination. The parents of patient 3, whose DNA was available for testing, do not display the mutation, indicating that the 2 bp deletion arose de novo in this patient.
to accurate neuronal migration to the cortex, and it apcortex. The reeler and scrambler mutations cause essentially the same phenotype pears that Doublecortin may function in this signaling pathway. The mouse disabled homolog 1 (mdab1) has and share gross similarity to lissencephaly and double cortex, since in all cases migrating cortical neurons very recently been identified as the gene mutated in the scrambler mouse (Ware et al., 1997) , which is characterseem to be unable to penetrate and migrate past a preexisting population of older neurons. The reeler gene ized by a severe abnormality of neuronal migration. mDab1 was identified by virtue of its physical binding encodes a large secreted polypeptide, called Reelin, with structural homology to extracellular matrix proto Src and also binds other nonreceptor tyrosine kinases such as Abl and Fyn (Howell et al., 1997) . Although mutateins such as Tenascin (D'Arcangelo et al., 1995) . The identity of the scrambler gene as mdab1, encoding a tions in Src and Fyn appear to play a role in axon and neurite outgrowth (Beggs et al., 1994 (Beggs et al., , 1997 Ignelzi et protein evidently involved in signal transduction at the plasma membrane, is consistent with the view that the al., 1994), engineered mutations in src (Rusanescu et al., 1995) and fyn (Stein et al., 1992) have not been mDab1 protein is involved in Reelin receptor signaling, although mDab1 is unlikely to represent the receptor reported to affect the migration of cortical neurons.
Although engineered mutations in the abl gene have protein itself. Thus, the similarity of the mouse and human neuronal migration disorders may reveal a large not been reported to cause neurons to migrate abnormally in the cortex (Schwartzberg et al., 1991; Tybulew- number of interacting proteins (perhaps forming a large complex) that transduce a signal through Abl, mDab1, icz et al., 1991), there are several lines of evidence that implicate Abl signaling in neuronal migration. Although and Doublecortin from the plasma membrane to the cytoskeleton. mDab1 was identified based on its physical binding to Src (Howell et al., 1997) , it is homologous to Drosophila Given the possibility that mDab1 and Doublecortin may be part of a common signaling pathway, it will be disabled, which has been implicated in neuronal development through genetic interactions with the Drosophila interesting to determine whether engineered mutations in doublecortin cause a phenotype similar to mdab1 abl (Dabl) gene (Gertler et al., 1993) . Another gene identified based on its interaction with Dabl, enabled, has a mutations. Furthermore, there are likely to be lissencephaly loci in addition to Doublecortin and LIS1 (Domouse homolog, mena, that has recently been critically implicated in the migration of nonneuronal cells (Gertler byns et al., 1992) , and the human homologs of mdab1 and reelin may represent candidate loci for this type of et al., 1996) . These genetic studies in Drosophila strongly suggest that physical interactions between mDab1 and developmental brain abnormality. other signaling proteins are necessary for normal process outgrowth and that Abl or close relatives of Abl In the mouse, the reeler mutation has been the parafrom Research Genetics as PCR-ready pools and screened according to the manufacturer's instructions. A second BAC library digm of abnormally targeted neuronal migration to the was screened commercially by Genome Systems using a hybridizausing Qiagen columns, digested to completion with restriction enzymes, precipitated, and 5 g was loaded on a 1% agarose gel in tion-based strategy with AFM340za9. Cosmids were screened for the presence of STSs using PCR in microtiter arrays, with each well TAE buffer. The gel was run overnight at 70 V, denatured with 0.5 M NaOH/0.6 M NaCl, neutralized with 0.5 M Tris-HCl/0.6 M NaCl for containing DNA from a single cosmid. 20 min each, transferred neutrally to a Hybond Nϩ nylon membrane overnight, fixed with NaOH, then blocked and hybridized as above Ligation-Mediated PCR at 60ЊC for 2-4 hr. In order to build a YAC and cosmid contig, the end sequence of individual clones was required. This was accomplished by end rescue using the vectorette method and "bubble PCR" by first digesting SSCP clones with blunt end restriction enzymes AluI, EcoRV, PvuII, and PCR reactions were run on a nondenaturing 6% acrylamide gel run RsaI, and ligating the vectorette to the blunt ends (Ogilvie and at 30 W for 2-4 hr at 4ЊC, and the DNA was visualized using the James, 1996). Nested PCR yielded at least one strong band that silver staining technique (Promega, Madison, WI). Aberrant bands was cut from the gel and sequenced in order to create an STS from were excised and the DNA was eluted (in 0.1% SDS/0.5 M ammothe end of the YAC or cosmid.
nium acetate/10 mM magnesium acetate/1 mM EDTA at 37ЊC for 1 hr), reamplified, and characterized by sequence analysis. For each patient who displayed an aberrant SSCP conformer, genomic DNA Cosmid Cloning ICRF YAC clone 4X148D1 was grown in AHC media, pelleted, and was reamplified and reanalyzed to confirm the suspected mutation. mixed with low-melt agarose. A partial 2 hr restriction digest with MboI was performed in agarose, the fragment size checked on a DNA Sequence Analysis pulse field gel to select for fragments centered at 50 kbp. The Su-DNA sequencing was performed using standard techniques on an perCos I vector (Stratagene, San Diego, CA) was prepared using ABI 377 automated sequencer, and DNA sequences were conmanufacturer's instructions. YAC DNA was extracted with phenolstructed, edited, and analyzed using the Sequencher program (Ann chloroform and ligated with vector DNA overnight using T4 DNA Arbor, MI). All DNA sequences were analyzed using the BLAST ligase. Ligation was checked on a 0.8% agarose gel for the presence program to detect matches to previously known DNA sequence. of high molecular weight concatemers. The ligation reaction was packaged using the Gigapack II gold lambda kit and transfected Patient Identification into XL1-Blue MR host cells (Stratagene), titered, and the resultant Patients were recruited through their neurologists in accordance clones lifted, fixed onto positively charged membranes, and hybridwith protocols approved by the Committees on Clinical Investigation ized with labeled total human DNA to identify clones with a human at Beth Israel Deaconess Medical Center, Children's Hospital, and insert. Ninety-six positive clones were chosen and gridded into a Fairview-University Medical Center. All patients entered into the microtiter plate. study had a brain MRI scan using standard clinical scanning sequences. MRIs from members of pedigrees were reviewed by one FISH of us (J. G. G., C. A. W., W. B. D., M. E. R.). MRI reports from single Total cosmid DNA was labeled and used as a probe for FISH on sporadic cases were not always reviewed; thus, sporadic cases are the parental X;2 translocation cell line (Coriell Cell Repository likely to be somewhat genetically heterogeneous. Several asymp#GM12514a). FISH was performed commercially (Genome Systomatic parents of affected patients also had brain MRI scans when tems).
their disease status was not clear.
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